FlowOx™ by Otivio

Otivio is a small medtech development company based in Oslo, Norway. Our vision is to stimulate active self care and treatment through simple and easy to use home treatment devices and services.

BIOGRAPHY

FlowOx™ by Otivio is a new direction in self healthcare

Otivio AS is a privately owned company based in Oslo, Norway. The company was founded in 2010 based on IP, prototypes and clinical data developed at University of Oslo. Otivio is ISO 13485 certified. Our main product FlowOx™ is a non-invasive medical device for home use addressing insufficient blood flow to the limbs associated with peripheral arterial disease, diabetes and other medical conditions. These conditions lead to pain, chronic wounds and amputations.

FlowOx™ is documented to improve these outcomes which have a big impact on Quality of Life and health care costs. FlowOx™ represents a solution for transition from hospital to home treatment accentuated by the COVID-19 outbreak. FlowOx™ is CE marked (CE2460) and available in numerous countries.

EMPLOYEES

Who are we at Otivio?

The management team of Otivio has, on average, more than 20 years of experience in the life science industry.

Andreas Mollatt

CEO

+47 934 46 261
am@otivio.com

Iacob Mathiesen

CSO

+47 468 90 416
im@otivio.com

Claus Kjærsgaaard

CCO, Head of Business Development and Strategy

+45 538 49 718
ck@otivio.com

Brian Alberts

QA Manager

+47 930 05 210
ba@otivio.com

Punit Patel

COO & Head of QA/RA

+47 930 14 786
pp@otivio.com

Henrik Hoel

Head of Medical Affairs

hh@otivio.com

Tarwinder Singh

Supplier Quality Leader

+47 465 26 169
ts@otivio.com

Hans Petter Tjeldflaat

CFO

hpt@otivio.com

ABOUT FLOWOX™

FlowOx™ in the Press

Otivio has developed FlowOx™ for patients suffering from the effects of PAD such as leg pain and chronic wounds. Early long-term testing documents increased blood flow.

Medwatch 25. september 2024

Medtech company Otivio is on a strong trajectory as it moves toward commercializing its pressure…

Otivio raised NOK 40 million.

In the second quarter of this year, Otivio raised NOK 40 million for the continued…

Article in Annals of Vascular Surgery

The Effect of 12-Week Treatment with Intermittent Negative Pressure on Blood Flow Velocity and Flowmotion,…

Article in Hospital Hub

“Norwegian healthtech company, Otivio has announced that it has extended an exploratory clinical trial with…

Article in Health Tech World

After Otivio came across a significant discovery for a potential new application for their device…

Medtech article on Otivio’s MS Discovery

The Norwegian company is applying a simple physiological response to costly and tricky-to-manage conditions, its…

COOPERATIVE PARTNERS

With a little help

Otivio has a strong setup of partners and suppliers all the way from design, development and manufacturing to clinical documentation, sales and distribution.

Norway Health Tech

Oslo, Norway

Norway Health Tech is a health technology cluster, dedicated to accelerating and supporting the development of new medtech, eHealth products, services and innovative solutions for the Norwegian and global health care market.

Innokas Medical

Kempele, Finland

Innokas Medical have been producing health technology since 1994. They focus on design and manufacturing of medical equipment under the world’s leading brand names in accordance with their specific strategy and values.

Oslo University Hospital

Aker, Norway

The heart, lung and vascular clinic at Oslo University hospital is Scandinavia’s largest center for cardiovascular disease treatment.

Special Plast

Gislaved, Sweden

Specialplast has been producing MedTech devices in and outside clean room since 1995. We are a quality focused subcontractor who develops and produces items in close cooperation with our customers.

mediq Innovation Experts GmbH

Frankfurt, Germany

mediq is a strategy and innovation consulting firm for the German and European healthcare market. We specialize in strategy development for technology and service innovations.